NASDAQ · BGMS
Bio Green Med Solution, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for BGMS: Nov 12, 2026
Bio Green Med Solution, Inc. Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-1.31.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Quiver Quantitative · BNK Invest- RTTNews · Jun 9, 9:19 AM EDTPre-Market Movers: RGNT, FEED, BYAH Swing Big(RTTNews) – Biotech companies are seeing significant pre-market activity this Tuesday, suggesting potential opportunities.
- RTTNews · Jun 5, 9:14 AM EDTPre-Market Movers: BGMS, CMND, INDP Chart The Course(RTTNews) – Pre-market trading offers an early glimpse of biotech stocks likely to attract investor attention this Friday.
- RTTNews · Jun 4, 11:37 PM EDTBio Green Med Solution Shares Surge 186% On Business Combination Agreement(RTTNews) – Shares of Bio Green Med Solution, Inc. (BGMS) jumped more than 186% overnight following the announcement of a definitive Business Combination Agreement to acquire Future NRG Sdn. Bhd., a Malaysia-based technology integrator specializing in sustainable medical waste ma
- Quiver Quantitative · Jul 16, 9:16 AM EDTCyclacel Pharmaceuticals Addresses Recent Stock Price Volatility Amid Ongoing Business DevelopmentsCyclacel Pharmaceuticals addresses stock price volatility, confirming no significant operational changes prior to recent fluctuations.
- Quiver Quantitative · Jul 7, 6:11 AM EDTCyclacel Pharmaceuticals Enters Amendment to Exchange Agreement with FITTERS Diversified BerhadCyclacel Pharmaceuticals amends exchange agreement with FITTERS to acquire subsidiary shares and issue stock as consideration.
- Quiver Quantitative · Jul 7, 6:11 AM EDTCyclacel Pharmaceuticals Highlights Study on PLK1 Inhibitor Potential for Treating Fibrolamellar Hepatocellular CarcinomaCyclacel Pharmaceuticals discusses the potential of plogosertib as a treatment for fibrolamellar carcinoma based on recent research findings.
- Quiver Quantitative · Jul 2, 9:13 AM EDTCyclacel Pharmaceuticals Announces 1-for-15 Reverse Stock Split Effective July 7, 2025Cyclacel Pharmaceuticals announces a 1-for-15 reverse stock split effective July 7, 2025, impacting all shareholders equally.
- Quiver Quantitative · Jun 20, 4:41 PM EDTCyclacel Pharmaceuticals Secures $3 Million in Private Placement of Convertible Preferred StockCyclacel Pharmaceuticals announces a $3 million private placement of convertible Series F Preferred Stock and related warrants for working capital.
- Quiver Quantitative · Jun 3, 4:21 PM EDTCyclacel Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RequirementCyclacel Pharmaceuticals has regained compliance with Nasdaq's minimum bid price requirement as of June 2, 2025.
- Quiver Quantitative · May 15, 1:00 AM EDTCyclacel Pharmaceuticals Reports Q1 2025 Financial Results and Strategic Focus Shifts to Plogosertib DevelopmentCyclacel Pharmaceuticals reports Q1 2025 results, focuses on plogosertib development after subsidiary liquidated, and explores financing options.
- Quiver Quantitative · May 7, 9:13 AM EDTCyclacel Pharmaceuticals Announces 1-for-16 Reverse Stock Split Effective May 12, 2025Cyclacel Pharmaceuticals announces a 1-for-16 reverse stock split effective May 12, 2025, impacting all shareholders uniformly.
- BNK Invest · Apr 29, 12:09 PM EDTTuesday Sector Leaders: Cigarettes & Tobacco, DrugsIn trading on Tuesday, cigarettes & tobacco shares were relative leaders, up on the day by about 0.9%. Leading the group were shares of Universal, up about 1.9% and shares of Altria Group up about 1% on the day. Also showing relative strength are drugs shares, up on the da
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Bio Green Med Solution, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.